These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18335226)

  • 61. Comparison of GnRH antagonist and agonist mini-dose long protocols in infertile cases undergoing controlled ovarian hyperstimulation.
    Akin H; Kumbasar S; Sik BA; Salman S; Temur M; Cakiroglu F; Ozyurt R; Kucukbas M
    Clin Exp Obstet Gynecol; 2017; 44(1):116-121. PubMed ID: 29714879
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
    Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
    Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Letrozole and gonadotropins versus luteal estradiol and gonadotropin-releasing hormone antagonist protocol in women with a prior low response to ovarian stimulation.
    Elassar A; Engmann L; Nulsen J; Benadiva C
    Fertil Steril; 2011 Jun; 95(7):2330-4. PubMed ID: 21514582
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?
    Elassar A; Nulsen J; Engmann L; Benadiva C
    J Reprod Med; 2015; 60(5-6):199-204. PubMed ID: 26126304
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A comparison of treatment results of the different treatment protocols in patients with poor ovarian response.
    Sanverdi I; Kutlu HT; Bilgic BE; Incebiyik A
    Gynecol Endocrinol; 2018 Jun; 34(6):524-527. PubMed ID: 29258385
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microdose flare-up vs. flexible-multidose GnRH antagonist protocols for poor responder patients who underwent ICSI.
    Esinler I
    Clin Exp Obstet Gynecol; 2014; 41(4):384-8. PubMed ID: 25134281
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined treatment with gonadotrophin releasing hormone agonist and gonadotrophins in poor responders to hyperstimulation for in vitro fertilization (IVF): clinical and endocrine results.
    McKenna KM; Foster P; McBain J; Martin M; Johnston WI
    Aust N Z J Obstet Gynaecol; 1989 Nov; 29(4):428-32. PubMed ID: 2517193
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome to a randomized controlled trial comparing gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist protocols.
    Toftager M; Sylvest R; Schmidt L; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Pinborg A
    Fertil Steril; 2018 Jan; 109(1):154-164. PubMed ID: 29175067
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparative study of high fixed-dose and decremental-dose regimens of gonadotropins in a minidose gonadotropin-releasing hormone agonist flare protocol for poor responders.
    Cedrin-Durnerin I; Bständig B; Hervé F; Wolf J; Uzan M; Hugues J
    Fertil Steril; 2000 May; 73(5):1055-6. PubMed ID: 10785239
    [No Abstract]   [Full Text] [Related]  

  • 71. Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation.
    Bonduelle M; Oberyé J; Mannaerts B; Devroey P
    Hum Reprod; 2010 Jun; 25(6):1433-40. PubMed ID: 20378616
    [TBL] [Abstract][Full Text] [Related]  

  • 72. GnRH antagonist in IVF poor-responder patients: results of a randomized trial.
    Marci R; Caserta D; Dolo V; Tatone C; Pavan A; Moscarini M
    Reprod Biomed Online; 2005 Aug; 11(2):189-93. PubMed ID: 16168215
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of in vivo GnRH agonist and GnRH antagonist on hCG and insulin-stimulated progesterone production by human granulosa-lutein cells in vitro.
    Mitwally MF; Casper RF
    J Assist Reprod Genet; 2002 Aug; 19(8):384-9. PubMed ID: 12182445
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of GnRH antagonist cycles with and without oral contraceptive pretreatment in potential poor prognosis patients.
    Bendikson K; Milki AA; Speck-Zulak A; Westphal LM
    Clin Exp Obstet Gynecol; 2006; 33(3):145-7. PubMed ID: 17089576
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data.
    Out HJ; Mannaerts BM
    Hum Fertil (Camb); 2002 Feb; 5(1):G5-10; discussion G10-2, G41-8. PubMed ID: 11939160
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of follicular fluid and serum cytokine concentrations in women undergoing assisted reproductive treatment with GnRH agonist long and antagonist protocols.
    Ficicioglu C; Kumbak B; Akcin O; Attar R; Yildirim G; Yesildaglar N
    Gynecol Endocrinol; 2010 Mar; 26(3):181-6. PubMed ID: 19718559
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of duration and dose of gonadotrophins on IVF outcomes.
    Martin JR; Mahutte NG; Arici A; Sakkas D
    Reprod Biomed Online; 2006 Nov; 13(5):645-50. PubMed ID: 17169173
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model.
    Knudtson JF; Tellez Santos M; Failor CM; Binkley PA; Venesky JP; Tekmal RR; Robinson RD; Schenken RS
    Reprod Sci; 2017 Sep; 24(9):1280-1283. PubMed ID: 28290768
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles.
    Eftekhar M; Mohammadian F; Yousefnejad F; Khani P
    Int J Fertil Steril; 2013 Jan; 6(4):266-71. PubMed ID: 24520450
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A rational approach to the management of low responders in in-vitro fertilization.
    Karande V; Gleicher N
    Hum Reprod; 1999 Jul; 14(7):1744-8. PubMed ID: 10402380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.